Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation
Imaging Technology
MARCH 15, 2024
Published by the FDA’s Center for Biologics Evaluation and Research (CBER), the Center for Drug Evaluation and Research (CDER), and the Center for Devices and Radiological Health (CDRH), and the Office of Combination Products (OCP), this paper represents our longstanding commitment to protect public health and advance innovation.
Let's personalize your content